Key points are not available for this paper at this time.
BACKGROUND: Clinical experience has shown considerable potential benefits from long-term continuous medication for chronic or relapsing forms of schizophrenia. These benefits have not always been realised. AIMS: To review the research literature in order to understand the problems of long-term medication and use of antipsychotic oral medication and long-acting injections (LAIs), and to place these in an historical context. METHOD: Review of literature. RESULTS: Research showed that the potential success of LAI therapy depends on the quality of the follow-up service. CONCLUSIONS: Following the advent of second-generation oral antipsychotics confidence in the use of LAIs has eroded and that mistakes made in LAI use during the past century may be repeated.
D. A. W. Johnson (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: